(Q34031071)

30 July 2017

1 reference

https://doi.org/10.1016/S0387-7604(00)00138-8

1 reference

29 December 2023

title

Approach to ex vivo gene therapy in the treatment of Parkinson's disease (English)

1 reference

30 July 2017

0 references

1 reference

Ishida A

1

1 reference

30 July 2017

Yasuzumi F

series ordinal

2

1 reference

30 July 2017

publication date

1 September 2000

1 reference

30 July 2017

published in

Brain and Development

1 reference

30 July 2017

volume

22 Suppl 1

1 reference

30 July 2017

page(s)

S143-7

1 reference

Non-viral approaches to gene therapy

30 July 2017

cites work

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/S0387-7604(00)00138-8

Myoblast-based gene therapies

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/S0387-7604(00)00138-8

Retroviruses as vectors

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/S0387-7604(00)00138-8

Genetically modified skin fibroblasts persist long after transplantation but gradually inactivate introduced genes

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/S0387-7604(00)00138-8

Fetal homotransplants (ventral mesencephalon and adrenal tissue) to the striatum of parkinsonian subjects

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/S0387-7604(00)00138-8

FGF-2-mediated protection of cultured mesencephalic dopaminergic neurons against MPTP and MPP+: specificity and impact of culture conditions, non-dopaminergic neurons, and astroglial cells

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/S0387-7604(00)00138-8

Transplanted xenogeneic neural cells in neurodegenerative disease models exhibit remarkable axonal target specificity and distinct growth patterns of glial and axonal fibres.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/S0387-7604(00)00138-8

Practical aspects of the development of ex vivo and in vivo gene therapy for Parkinson's disease

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/S0387-7604(00)00138-8

In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/S0387-7604(00)00138-8

Mesencephalic dopaminergic neurons protected by GDNF from axotomy-induced degeneration in the adult brain

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/S0387-7604(00)00138-8

Generation of DOPA-producing astrocytes by retroviral transduction of the human tyrosine hydroxylase gene: in vitro characterization and in vivo effects in the rat Parkinson model

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/S0387-7604(00)00138-8

Novel therapeutic directions for Parkinson's disease

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/S0387-7604(00)00138-8

Effects of the age of donor or host tissue on astrocyte migration from intracerebral xenografts of corpus callosum

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/S0387-7604(00)00138-8

Survival of implanted fetal dopamine cells and neurologic improvement 12 to 46 months after transplantation for Parkinson's disease

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/S0387-7604(00)00138-8

Survival and function of intrastriatally grafted primary fibroblasts genetically modified to produce l-dopa

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/S0387-7604(00)00138-8

Glial cell line-derived neurotrophic factor exerts neurotrophic effects on dopaminergic neurons in vitro and promotes their survival and regrowth after damage by 1-methyl-4-phenylpyridinium.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/S0387-7604(00)00138-8

Brain-derived neurotrophic factor protects dopamine neurons against 6-hydroxydopamine and N-methyl-4-phenylpyridinium ion toxicity: involvement of the glutathione system

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/S0387-7604(00)00138-8

Gene therapy for neurologic disease

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/S0387-7604(00)00138-8

In vivo L-DOPA production by genetically modified primary rat fibroblast or 9L gliosarcoma cell grafts via coexpression of GTPcyclohydrolase I with tyrosine hydroxylase

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/S0387-7604(00)00138-8

Identifiers

DOI

10.1016/S0387-7604(00)00138-8

1 reference

30 July 2017

1 reference